$1.30
al cierre: Aug 20 EDT
$1.31
0.010.77%
Pre-comercialización: 7:43 AM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Pacific Biosciences informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 6
Estimación de BPA
$-0.159
Estimación de ingresos trimestrales
$40.23M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$156.11M
Analice el historial de beneficios de Pacific Biosciences utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PACB | Pacific Biosciences | -$0.17 | -$0.16 | — | — | $39.97M | $40.23M | — | — | 11/06/2025 | |
PACB | Pacific Biosciences | -$0.20 | -$0.17 | -$0.13 | 23.53% | $36.01M | $36.89M | $39.77M | 9.04% | 08/07/2025 | |
PACB | Pacific Biosciences | -$0.26 | -$0.19 | -$0.15 | 21.05% | $38.81M | $34.81M | $37.15M | 0.69% | 05/08/2025 | |
PACB | Pacific Biosciences | -$0.27 | -$0.21 | -$0.20 | 4.76% | $58.36M | $40.16M | $39.22M | -2.33% | 02/13/2025 | |
PACB | Pacific Biosciences | -$0.27 | -$0.22 | -$0.17 | 22.73% | $55.69M | $41.95M | $39.97M | -4.75% | 11/07/2024 | |
PACB | Pacific Biosciences | -$0.26 | -$0.23 | -$0.20 | 13.04% | $47.57M | $40.88M | $36.01M | -12.23% | 08/07/2024 | |
PACB | Pacific Biosciences | -$0.31 | -$0.27 | -$0.26 | 3.70% | $38.90M | $42.96M | $38.81M | -9.66% | 05/09/2024 | |
PACB | Pacific Biosciences | -$0.35 | -$0.28 | -$0.27 | 3.57% | $27.35M | $57.49M | $58.36M | 1.51% | 02/15/2024 | |
PACB | Pacific Biosciences | -$0.32 | -$0.32 | -$0.27 | 15.62% | $32.31M | $48.76M | $55.69M | 14.21% | 10/30/2023 | |
PACB | Pacific Biosciences | -$0.34 | -$0.16 | -$0.26 | 18.75% | $35.47M | $49.30M | $47.57M | 18.05% | 08/02/2023 | |
PACB | Pacific Biosciences | -$0.37 | -$0.17 | -$0.31 | 6.06% | $33.17M | $45.14M | $38.90M | 13.15% | 05/02/2023 | |
PACB | Pacific Biosciences | -$0.30 | -$0.18 | -$0.35 | 2.78% | $36.02M | $42.00M | $27.35M | 4.24% | 02/16/2023 | |
PACB | Pacific Biosciences | -$0.23 | -$0.20 | -$0.32 | 3.03% | $34.89M | $40.50M | $32.31M | -8.73% | 11/07/2022 | |
PACB | Pacific Biosciences | -$0.21 | -$0.32 | -$0.34 | -6.25% | $30.61M | $35.70M | $35.47M | -0.65% | 08/03/2022 | |
PACB | Pacific Biosciences | -$0.45 | -$0.31 | -$0.37 | -19.35% | $29.00M | $32.82M | $33.17M | 1.08% | 05/04/2022 | |
PACB | Pacific Biosciences | $0.37 | -$0.28 | -$0.30 | -7.14% | $27.14M | $36.12M | $36.02M | -0.28% | 02/15/2022 | |
PACB | Pacific Biosciences | -$0.14 | -$0.22 | -$0.23 | -4.55% | $19.08M | $33.23M | $34.89M | 4.99% | 11/02/2021 | |
PACB | Pacific Biosciences | -$0.15 | -$0.20 | -$0.21 | -5.00% | $17.08M | $29.89M | $30.61M | 2.41% | 08/03/2021 | |
PACB | Pacific Biosciences | $0.01 | -$0.45 | -$0.45 | 0.00% | $15.60M | $25.67M | $29.00M | 12.96% | 04/29/2021 | |
PACB | Pacific Biosciences | $0.00 | $0.32 | $0.37 | 15.62% | $27.93M | $25.41M | $27.14M | 6.79% | 02/10/2021 | |
PACB | Pacific Biosciences | -$0.19 | -$0.13 | -$0.14 | -7.69% | $21.91M | $20.35M | $19.08M | -6.23% | 11/02/2020 |
Pacific Biosciences (PACB) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $-0.13 | $-0.17 | 23.5 % |
| Q1 | 2025-05-08 | $-0.15 | $-0.19 | 21.1 % |
| Q4 | 2025-02-13 | $-0.20 | $-0.21 | 4.76 % |
| Q3 | 2024-11-07 | $-0.17 | $-0.22 | 22.7 % |
Pacific Biosciences (PACB) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $39.77M | $36.89M | 9.04 % |
| Q1 | 2025-05-08 | $37.15M | $34.81M | 0.69 % |
| Q4 | 2025-02-13 | $39.22M | $40.16M | -2.33 % |
| Q3 | 2024-11-07 | $39.97M | $41.95M | -4.75 % |
PREGUNTAS FRECUENTES
¿Cuándo Pacific Biosciences (NASDAQ:PACB) publicará los resultados?
Está previsto que Pacific Biosciences (PACB) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 7, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Pacific Biosciences (NASDAQ:PACB)?
El BPA real fue de $-0.13, que superó la estimación de $-0.17.
¿Cuáles fueron los ingresos de Pacific Biosciences (NASDAQ:PACB)?
Los ingresos reales fueron $39.8M, que superó la estimación de $36.9M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.